List of Tables

Table 1. Phosphodiesterase Inhibitor Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Phosphodiesterase Inhibitor Market Restraints

Table 3. Phosphodiesterase Inhibitor Market Trends

Table 4. Phosphodiesterase Inhibitor Industry Policy

Table 5. Global Phosphodiesterase Inhibitor Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Phosphodiesterase Inhibitor Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Phosphodiesterase Inhibitor Sales Quantity by Company, (2020-2025) & (MT), Ranked Based on Sales in 2024

Table 8. Global Phosphodiesterase Inhibitor Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Phosphodiesterase Inhibitor Average Selling Price (ASP) by Company, (2020-2025) & (US$/Ton)

Table 10. Global Phosphodiesterase Inhibitor Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Phosphodiesterase Inhibitor Mergers & Acquisitions, Expansion Plans

Table 12. Global Phosphodiesterase Inhibitor Manufacturers Product Type

Table 13. Head Office and Phosphodiesterase Inhibitor Production Site of Key Manufacturer

Table 14. Phosphodiesterase Inhibitor Capacity of Major Manufacturers and Future Plan

Table 15. China Phosphodiesterase Inhibitor Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Phosphodiesterase Inhibitor Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Phosphodiesterase Inhibitor Sales Quantity by Company, (2020-2025) & (MT), Ranked Based on Sales in 2024

Table 18. China Phosphodiesterase Inhibitor Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Phosphodiesterase Inhibitor Production & Forecast by Region, 2020 VS 2024 VS 2031, (MT)

Table 20. Global Phosphodiesterase Inhibitor Production by Region, 2020-2025, (MT)

Table 21. Global Phosphodiesterase Inhibitor Production Forecast by Region, 2026-2031, (MT)

Table 22. Global Key Players of Phosphodiesterase Inhibitor Upstream (Raw Materials)

Table 23. Global Phosphodiesterase Inhibitor Typical Customers

Table 24. Phosphodiesterase Inhibitor Typical Distributors

Table 25. by Type, Global Phosphodiesterase Inhibitor Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Phosphodiesterase Inhibitor Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Phosphodiesterase Inhibitor Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Phosphodiesterase Inhibitor Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Table 30. By Country, Global Phosphodiesterase Inhibitor Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Phosphodiesterase Inhibitor Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Phosphodiesterase Inhibitor Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Table 34. By Country, Global Phosphodiesterase Inhibitor Sales Quantity Market Share, 2020-2031

Table 35. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 36. Pfizer Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 37. Pfizer Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 38. Pfizer Company Profile and Main Business

Table 39. Pfizer Recent Developments

Table 40. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 41. Amgen Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 42. Amgen Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 43. Amgen Company Profile and Main Business

Table 44. Amgen Recent Developments

Table 45. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 46. AstraZeneca Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 47. AstraZeneca Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 48. AstraZeneca Company Profile and Main Business

Table 49. AstraZeneca Recent Developments

Table 50. Teva Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 51. Teva Pharmaceuticals Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 52. Teva Pharmaceuticals Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 53. Teva Pharmaceuticals Company Profile and Main Business

Table 54. Teva Pharmaceuticals Recent Developments

Table 55. Aurobindo Company Information, Head Office, Market Area, and Industry Position

Table 56. Aurobindo Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 57. Aurobindo Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 58. Aurobindo Company Profile and Main Business

Table 59. Aurobindo Recent Developments

Table 60. Bristol Labs Company Information, Head Office, Market Area, and Industry Position

Table 61. Bristol Labs Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 62. Bristol Labs Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 63. Bristol Labs Company Profile and Main Business

Table 64. Bristol Labs Recent Developments

Table 65. Senju Pharmaceutical Co Company Information, Head Office, Market Area, and Industry Position

Table 66. Senju Pharmaceutical Co Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 67. Senju Pharmaceutical Co Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 68. Senju Pharmaceutical Co Company Profile and Main Business

Table 69. Senju Pharmaceutical Co Recent Developments

Table 70. Cipla Ltd Company Information, Head Office, Market Area, and Industry Position

Table 71. Cipla Ltd Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 72. Cipla Ltd Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 73. Cipla Ltd Company Profile and Main Business

Table 74. Cipla Ltd Recent Developments

Table 75. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 76. Sanofi Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 77. Sanofi Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 78. Sanofi Company Profile and Main Business

Table 79. Sanofi Recent Developments

Table 80. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 81. Qilu Pharmaceutical Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 82. Qilu Pharmaceutical Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 83. Qilu Pharmaceutical Company Profile and Main Business

Table 84. Qilu Pharmaceutical Recent Developments

Table 85. Ajanta Pharma Company Information, Head Office, Market Area, and Industry Position

Table 86. Ajanta Pharma Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 87. Ajanta Pharma Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 88. Ajanta Pharma Company Profile and Main Business

Table 89. Ajanta Pharma Recent Developments

Table 90. Lupin Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 91. Lupin Pharmaceuticals Phosphodiesterase Inhibitor Models, Specifications, and Application

Table 92. Lupin Pharmaceuticals Phosphodiesterase Inhibitor Sales Quantity (MT), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2020-2025

Table 93. Lupin Pharmaceuticals Company Profile and Main Business

Table 94. Lupin Pharmaceuticals Recent Developments

List of Figures

Figure 1. Phosphodiesterase Inhibitor Picture

Figure 2. Global Phosphodiesterase Inhibitor Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Phosphodiesterase Inhibitor Sales Quantity, (MT) & (2020-2031)

Figure 4. Global Phosphodiesterase Inhibitor Average Selling Price (ASP), (2020-2031) & (US$/Ton)

Figure 5. China Phosphodiesterase Inhibitor Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Phosphodiesterase Inhibitor Sales Quantity (MT) & (2020-2031)

Figure 7. China Phosphodiesterase Inhibitor Average Selling Price (ASP), (US$/Ton) & (2020-2031)

Figure 8. By Consumption Value, China Phosphodiesterase Inhibitor Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Phosphodiesterase Inhibitor Market Share of Global, 2020-2031

Figure 10. Global Phosphodiesterase Inhibitor Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Phosphodiesterase Inhibitor Key Participants, Market Share, 2024

Figure 12. Global Phosphodiesterase Inhibitor Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Phosphodiesterase Inhibitor Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Phosphodiesterase Inhibitor Production Market Share & Forecast by Region, 2020-2031

Figure 15. Phosphodiesterase Inhibitor Industry Chain

Figure 16. Phosphodiesterase Inhibitor Procurement Model

Figure 17. Phosphodiesterase Inhibitor Sales Model

Figure 18. Phosphodiesterase Inhibitor Sales Channels, Direct Sales, and Distribution

Figure 19. PDE5 Inhibitors

Figure 20. PDE4 Inhibitors

Figure 21. PDE3 Inhibitors

Figure 22. Others

Figure 23. by Type, Global Phosphodiesterase Inhibitor Consumption Value, 2020-2031, US$ Million

Figure 24. by Type, Global Phosphodiesterase Inhibitor Consumption Value Market Share, 2020-2031

Figure 25. by Type, Global Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 26. by Type, Global Phosphodiesterase Inhibitor Sales Quantity Market Share, 2020-2031

Figure 27. by Type, Global Phosphodiesterase Inhibitor Average Selling Price (ASP), 2020-2031, (US$/Ton)

Figure 28. Hospital

Figure 29. Retail Pharmacy

Figure 30. Online Pharmacy

Figure 31. Other

Figure 32. by Application, Global Phosphodiesterase Inhibitor Consumption Value, 2020-2031, US$ Million

Figure 33. by Application, Global Phosphodiesterase Inhibitor Revenue Market Share, 2020-2031

Figure 34. by Application, Global Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 35. by Application, Global Phosphodiesterase Inhibitor Sales Quantity Market Share, 2020-2031

Figure 36. by Application, Global Phosphodiesterase Inhibitor Price, 2020-2031, (US$/Ton)

Figure 37. By Region, Global Phosphodiesterase Inhibitor Consumption Value Market Share, 2020-2031

Figure 38. By Region, Global Phosphodiesterase Inhibitor Sales Quantity Market Share, 2020-2031

Figure 39. North America Phosphodiesterase Inhibitor Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, North America Phosphodiesterase Inhibitor Consumption Value Market Share, 2024

Figure 41. Europe Phosphodiesterase Inhibitor Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country, Europe Phosphodiesterase Inhibitor Consumption Value Market Share, 2024

Figure 43. Asia Pacific Phosphodiesterase Inhibitor Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country/Region, Asia Pacific Phosphodiesterase Inhibitor Consumption Value Market Share, 2024

Figure 45. South America Phosphodiesterase Inhibitor Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. By Country, South America Phosphodiesterase Inhibitor Consumption Value Market Share, 2024

Figure 47. Middle East & Africa Phosphodiesterase Inhibitor Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 48. United States Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 49. by Type, United States Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, United States Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 51. Europe Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 52. by Type, Europe Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, Europe Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 54. China Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 55. by Type, China Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, China Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 57. Japan Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 58. by Type, Japan Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, Japan Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 60. South Korea Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 61. by Type, South Korea Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, South Korea Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 63. Southeast Asia Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 64. by Type, Southeast Asia Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, Southeast Asia Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 66. India Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 67. by Type, India Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, India Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 69. Middle East & Africa Phosphodiesterase Inhibitor Sales Quantity, 2020-2031, (MT)

Figure 70. by Type, Middle East & Africa Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 71. by Application, Middle East & Africa Phosphodiesterase Inhibitor Sales Quantity Market Share, 2024 VS 2031

Figure 72. Research Methodology

Figure 73. Breakdown of Primary Interviews

Figure 74. Bottom-up Approaches

Figure 75. Top-down Approaches